$99.99
Tirzepatide is a dual incretin receptor agonist studied for its role in metabolic regulation. It is widely researched for improving glucose control, supporting insulin sensitivity, and influencing weight management pathways.
Tirzepatide is a synthetic peptide that acts as a dual agonist for GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors. This dual mechanism makes it a unique compound in metabolic and endocrine research. It is extensively studied for its effects on glucose metabolism, appetite regulation, and overall metabolic efficiency.
Tirzepatide works by activating both GIP and GLP-1 receptors, which play key roles in regulating glucose metabolism. This leads to enhanced insulin secretion in response to food intake and reduced glucagon levels, helping maintain stable blood glucose levels.
It also slows gastric emptying and influences appetite regulation, contributing to reduced caloric intake in research models. The combined receptor activity results in improved metabolic efficiency and energy balance.
This dual-action mechanism sets Tirzepatide apart from single-pathway incretin-based compounds.
Tirzepatide has been extensively studied in metabolic and endocrine research, particularly in models related to insulin resistance, obesity, and type 2 diabetes. Its dual receptor activity has shown promising results in improving glycemic control and supporting weight management pathways.
Research also explores its effects on lipid metabolism, cardiovascular markers, and long-term metabolic health. Its ability to target multiple metabolic pathways makes it a significant compound in advanced metabolic research.
Ongoing studies continue to evaluate its broader applications in metabolic optimization and chronic condition management.
| Strengh | 5mg, 10mg, 15mg, 20mg, 30mg, 40mg, 45mg, 50mg, 60mg |
|---|
Reviews
There are no reviews yet.